Nida El Islem Guissi

Dr. Nida El Islem Guissi

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2019 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MCMinglei Chen
Minglei Chen
KJKambere Amerigos Daddy J.C.
Kambere Amerigos Daddy J.C.
ZSZhigui Su
Zhigui Su
NGNida El Islem Guissi
Nida El Islem Guissi
YXYanyu Xiao
Yanyu Xiao
QPQineng Ping
Qineng Ping
Multifunctional nanomedicines with active targeting and stimuli-responsive drug release function utilizing pathophysiological features of the disease are regarded as an effective strategy for treatment of rheumatoid arthritis (RA). Under the inflammatory environment of RA, activated macrophages revealed increased expression of folate receptor and elevated intracellular reactive oxygen species (ROS) level. In this study, we successfully conjugated folate to polyethylene glycol 100 monostearate as film-forming material and further prepared methotrexate (MTX) and catalase (CAT) co-encapsulated liposomes, herein, shortened to FOL-MTX&CAT-L, that could actively target to activated macrophages. Thereafter, elevated intracellular hydrogen peroxide, the main source of ROS, diffused into liposomes and encapsulated CAT catalyzed the decomposition of hydrogen peroxide into oxygen and water. Continuous oxygen-generation inside liposomes would eventually disorganize its structure and release the encapsulated MTX. We characterized the in vitro drug release, cellular uptake and cytotoxicity studies as well as in vivo pharmacokinetics, biodistribution, therapeutic efficacy and safety studies of FOL-MTX&CAT-L. In vitro results revealed that FOL-MTX&CAT-L possessed sufficient ROS-sensitive drug release, displayed an improved cellular uptake through folate-mediated endocytosis and exhibited a higher cytotoxic effect on activated RAW264.7 cells. Moreover, in vivo results showed prolonged blood circulation time of PEGylated liposomes, enhanced accumulation of MTX in inflamed joints of collagen-induced arthritis (CIA) mice, reinforced therapeutic efficacy and minimal toxicity toward major organs. These results imply that FOL-MTX&CAT-L may be used as an effective nanomedicine system for RA treatment.

17 December 2014 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
FSFarouk Semcheddine
Farouk Semcheddine
NGNida El Islem Guissi
Nida El Islem Guissi
XLXueYin Liu
XueYin Liu
ZWZuoMin Wu
ZuoMin Wu
BWBo Wang
Bo Wang

2 August 2021 in Materials Horizons
Verified
Journal Article
Closed access
PDF file
FSFarouk Semcheddine
Farouk Semcheddine
NGNida El Islem Guissi
Nida El Islem Guissi
WLWeiwei Liu
Weiwei Liu
TATayyaba
Tayyaba
LGLv Gang
Lv Gang
Xuemei WangXuemei Wang
Xuemei Wang
In situ ex vivo bio-self-assembled ring-shaped DNA–Au nanostructures and DNA–Au nanostructures loaded exosomes with strong dual fluorescence and rapid cellular uptake, reaching the nucleus 10 min post-incubation as an outstanding theranostic platform.

31 August 2016 in RSC Advances
Verified
Journal Article
Closed access
PDF file
HLHuipeng Li
Huipeng Li
NGNida El Islem Guissi
Nida El Islem Guissi
ZSZhigui Su
Zhigui Su
QPQineng Ping
Qineng Ping
MSMinjie Sun
Minjie Sun
Nano-structured lipid carriers (NLCs) have been widely used for oral drug delivery due to their remarkable biocompatibility and biodegradability. In addition to formulation and particle size, particle surface properties are important for overcoming gastrointestinal (GI) barriers to oral drug delivery by lipid-based nanoparticles. In this study, we describe polyethylene glycol (PEG)-based mucus-penetrating NLCs and we report the effect of surface hydrophilic properties on their oral delivery across the GI mucus and intestinal epithelium cells in vivo and in vitro. The solvent evaporation method was used to prepare PEG-modified NLCs (pNLCs) with three different levels of polyethylene glycol (100) monostearate (S100) as the hydrophilic coating material. The stability and cytotoxicity of pNLCs, as well as their uptake by Caco-2 cells and transport across Caco-2 monolayers and mucus-secreting Caco-2/HT29 coculture monolayers, were investigated to confirm the optimal PEG level for oral delivery. In situ single-pass perfusion experiments, in vivo imaging and in vivo oral pharmacokinetic studies were also performed in rodents to evaluate the oral absorption of pNLCs with different hydrophilic surface properties. Our results showed that the hydration layer thickness of the pNLCs increased with the increasing S100 content. NLC containing 20% S100 (pNLC-20%) showed the highest uptake by Caco-2 cells and the most effective permeation through Caco-2/HT29 coculture monolayers compared with unmodified NLC, pNLC-40% and pNLC-80%. In addition, pNLC-20% was the most stable during the process of oral administration and uptake into the blood circulation, as judged by fluorescence resonance energy transfer (FRET). Moreover, in situ single-pass perfusion experiments, ligated intestinal loops tests, in vivo imaging and pharmacokinetics studies also demonstrated that pNLC-20% most rapidly penetrated the intestinal epithelium and had the highest AUC and Cmax of all the NLCs. In conclusion, optimization of surface hydrophilic properties is essential for enhancing the absorption of drugs delivered by oral administration of lipid-based nanocarriers.

24 February 2017 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
NGNida El Islem Guissi
Nida El Islem Guissi
HLHuipeng Li
Huipeng Li
YXYurui Xu
Yurui Xu
FSFarouk Semcheddine
Farouk Semcheddine
MCMinglei Chen
Minglei Chen
QPQineng Ping
Qineng Ping

27 March 2023 in ACS Applied Bio Materials
Verified
Journal Article
Closed access
LLLi Li
Li Li
XMXiaoxie Ma
Xiaoxie Ma
YPYusong Peng
Yusong Peng
JYJun Yin
Jun Yin
NGNida El Islem Guissi
Nida El Islem Guissi
WWWang Wang
Wang Wang